Co-medication and polypharmacy with ADHD medications in adults: a Swedish nationwide study Show others and affiliations
2020 (English) In: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 40, no Suppl. 1, p. S28-S29Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages Elsevier, 2020. Vol. 40, no Suppl. 1, p. S28-S29
National Category
Neurology
Identifiers URN: urn:nbn:se:oru:diva-88679 DOI: 10.1016/j.euroneuro.2020.09.043 ISI: 000593520800037 OAI: oai:DiVA.org:oru-88679 DiVA, id: diva2:1520168
Conference 33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP), Electronic Network, September 12-15, 2020
Funder Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01172
Note Funding Agencies:
European Union's Horizon 2020 research and innovation programme: Comorbid Conditions of ADHD CoCA 667302
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Mental Health (NIMH) R01MH102221
2021-01-202021-01-202021-01-20 Bibliographically approved